Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sonnet BioTherapeutics Holdings, Inc. - Common Stock
(NQ:
SONN
)
1.260
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Sonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formalizes the Company's Business Advisory Committee
September 26, 2022
Via
ACCESSWIRE
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
↗
September 23, 2022
Gainers
Via
Benzinga
Sonnet BioTherapeutics Provides Fiscal Year 2022 Third Quarter Business and Earnings Update
August 15, 2022
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Thursday
↗
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
Sonnet BioTherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
October 04, 2022
Via
ACCESSWIRE
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
↗
September 27, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 22, 2022
Gainers
Via
Benzinga
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
↗
September 22, 2022
Gainers
Via
Benzinga
Sonnet BioTherapeutics Announces Progress in Two Phase 1 Dose-Escalation Trials of SON-1010
September 21, 2022
Via
ACCESSWIRE
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
↗
September 20, 2022
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Via
Benzinga
US Markets Turn Higher As Dow Jumps Over 100 Points
↗
September 19, 2022
U.S. stocks traded higher in volatile trading toward the end of trading, with the Dow Jones gaining more than 100 points on Monday.
Via
Benzinga
Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed's Rate Decision
↗
September 19, 2022
U.S. stocks traded lower in volatile trading toward the end of trading, with the Dow Jones dropping around 40 points on Monday.
Via
Benzinga
Why Sonnet BioTherapeutics Shares Are Falling Over 30%
↗
September 19, 2022
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 36.9% to $1.72 during Monday's trading session after the company announced a 1-for-14 reverse stock split. What Else?
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
↗
September 19, 2022
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Via
Benzinga
US Stocks Open Lower; Housing Market Index Drops In September
↗
September 19, 2022
U.S. stocks traded lower this morning, after recording losses in the previous week.
Via
Benzinga
Why Sonnet BioTherapeutics Shares Are Falling Sharply
↗
September 16, 2022
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 15.24% to $0.19 Friday morning after the company announced a 1-for-14 reverse stock split. What Else?
Via
Benzinga
Sonnet BioTherapeutics Announces 1-for-14 Reverse Stock Split
September 16, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 15, 2022
Via
Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
↗
September 15, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.
Via
Benzinga
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
↗
September 16, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
September 15, 2022
Good morning! It's time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning!
Via
InvestorPlace
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
↗
September 15, 2022
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 14, 2022
Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
September 01, 2022
It's time for another breakdown of the biggest pre-market stock movers as we cover what's moving shares on Thursday morning!
Via
InvestorPlace
Why Nutanix Is Trading Higher By 16%; Here Are 33 Stocks Moving Premarket
↗
September 01, 2022
Gainers Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 02, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
July 27, 2022
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on!
Via
InvestorPlace
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
↗
July 27, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
